- Report
- March 2024
- 197 Pages
Global
From €3283EUR$3,374USD£2,812GBP
€3648EUR$3,749USD£3,125GBP
- Report
- January 2024
- 139 Pages
Global
From €3794EUR$3,899USD£3,250GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Report
- January 2024
- 200 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- March 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- April 2024
- 197 Pages
Global
From €4816EUR$4,950USD£4,126GBP
- Report
- May 2023
- 180 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1216EUR$1,250USD£1,042GBP
- Report
- April 2023
- 120 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- January 2022
- 115 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- August 2022
- 104 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9730EUR$10,000USD£8,335GBP
- Report
- July 2022
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- February 2020
- 231 Pages
Global
From €3503EUR$3,600USD£3,001GBP
- Drug Pipelines
- November 2020
- 72 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- December 2021
Global
From €23838EUR$24,500USD£20,421GBP
- Report
- October 2023
- 77 Pages
Global
From €3500EUR$3,853USD£3,103GBP
Gonadotropins are hormones that play a key role in the regulation of reproductive and sexual development. They are used to treat endocrine and metabolic disorders, such as hypogonadism, infertility, and delayed puberty. Gonadotropins are also used to induce ovulation in women with infertility.
Gonadotropin drugs are typically administered via injection, and are available in both synthetic and natural forms. Synthetic gonadotropins are typically used to treat infertility, while natural gonadotropins are used to treat hypogonadism.
The gonadotropin market is highly competitive, with a number of companies offering products for the treatment of endocrine and metabolic disorders. These companies include Merck, Ferring Pharmaceuticals, Teva Pharmaceuticals, and Ferring Pharmaceuticals. Other companies in the market include Pfizer, Novartis, and Sanofi. Show Less Read more